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Background 
Each day, clinicians work with patients to provide the necessary care to improve 
individuals’ health conditions. Clinicians use vast amounts of information to formulate decisions 
to treat patients. However, clinical practice guidelines are developed to help clinicians 
systematically treat a particular disease process, especially in the use of appropriately prescribing 
antibiotic therapies. Clinical practice guidelines are in place to help clinicians provide a 
standardized process of care based on current research that leads to positive patient outcomes.  
According to Darrat, Yaremchuk, Payne, & Nelson (2014), utilization of clinical practice 
guidelines are intended to improve quality of care and decrease ineffective therapeutic practices. 
Such practices include decreased antibiotic use, decreased healthcare-associated infections, 
decreased length of stays, and a decrease in a prevalence of antibiotic bacterial resistance 
(Laximinarayan et al., 2013).  Friedman et al., (2008) reported that consensus from clinicians 
combined with changes in behaviors and attitudes are necessities for successful implementation 
of clinical practice guidelines. Another benefit of appropriate application of clinical guidelines is 
that patients who receive the appropriate therapeutic treatments experience fewer side effects and 
increased patient satisfaction.  
 As an important piece of guideline adherence, providers should advise patients to use 
supportive treatments such as antihistamines, decongestants, corticosteroid nasal sprays, and 
nasal washings; as adjunctive treatments for ABRS and AVRS. Treatment guidelines that 
advocate prevention of antibiotic over-prescribing will also promote “watchful waiting” and 
 
supportive therapies with careful follow-up as regimens for patients with viral infections 
(Rosenfeld et al., 2015).  
Particular treatment guidelines factor in timing of symptoms as a way to assist providers 
to diagnose ABRS and AVRS. For example, if a patient presents with a set of symptoms that 
have been ongoing for ‘x’ number of days, then the provider can apply the treatment guideline to 
the patient’s symptoms and timing of the symptoms to provide an appropriate diagnosis and 
treatment plan. In diagnosing a viral sinus infection, the literature used the term acute viral 
rhinosinusitis (AVRS) to include upper respiratory infection (URI), viral syndrome, and viral 
infection/common cold. For a bacterial infection, the literature used the term acute bacterial 
rhinosinusitis (ABRS) which is associated with sinusitis and the specific sinus sites (maxillary, 
frontal, ethmoid, and sphenoid). 
Chow et al. (2012) developed a decision tree tool that examined acute bacterial 
rhinosinusitis (ABRS) symptoms with a timing component (symptoms for 3-4 days, 5-10 days, 
and >10 days). If symptomatic for 3-4 days, the patient’s symptoms had to include a fever > 
102F and purulent nasal drainage before diagnosis as ABRS was warranted. For a patient with 
symptoms for 5-10 days, her symptoms might be classified as “worsening” and the provider 
would have to ask: “Did your symptoms improve and then get worse?”  This ‘worsening’ state is 
typically known as “double sickening.” If the patient stated ‘yes’ to the critical question, then the 
patient would be diagnosed with ABRS correctly. Lastly, if symptomatic for greater than 10 
days, then the condition is known as “persistent” and the provider has to ask: “Are your 
symptoms improving?”  Most patients who are seeking treatment at this stage are not improving 
and would be diagnosed with ABRS.  
 
Despite the strong support for utilizing clinical practice guidelines, guideline adherence 
may be eroded by clinicians’ lack of familiarity with the guideline, inconsistent application, 
perception of interference with individualized care, or disagreement (File & Hadley, 2002; Gill 
et al., 2006). Typically, guidelines are vetted through rigorous systematic reviews, professional 
organizations and clinical experts.  However, guidelines are guides -not rules- that are to be 
applied in conjunction with the clinician’s experience and patient preference.  One challenge of 
guideline dissemination is creating sufficient adherence so that deviations from the guideline 
recommendations are exceptions (Laximinarayan et al., 2013).  
 Laximinarayan et al., (2013) stated that physicians are influenced by their peers and 
perceived demands from patients. Providers can be influenced by colleagues and their 
prescribing trends. Patient perception and expectation for certain treatments can also influence 
how a physician will prescribe a certain medication. This peer and patient influence might be a 
barrier to treatment guidelines adoption. With the expansion of consumer-driven healthcare and 
more knowledgeable patients, many patients come to a provider with preconceived notions of 
diagnosis and needed treatment. More patients, who have investigated their potential diagnosis 
and treatment, have led many providers to prescribe unnecessary antibiotics for illnesses, due to 
busy office schedules and desire to avoid unpleasant conflict with patients.  
Imprudent and hasty prescription of antibiotics for self-limited illnesses has led to the 
overgrowth of drug-resistant bacteria, such as methicillin-resistant Staphylococcus aureus and 
Clostridium difficile (Hickner et al., 2001).  Patients who are inappropriately treated with 
antibiotics have developed drug resistant bacteria, increased medical cost, increased time away 
from work, and increased time away from school (File & Hadley, 2002; Zoorob et al, 2012).  
 
Utilizing clinical practice guidelines could help control the number of unnecessary antibiotic 
prescriptions written. As previously stated, utilization and adherence of treatment guidelines will 
lead to improved patient outcomes. Potential benefits of adherence to clinical guidelines could 
include decreased costs to the healthcare system and to patients, reduction in antibiotic resistant 
bacteria, and reduction in antibiotic overprescribing. 
 Rhinosinusitis is a common medical condition that affects approximately 1 in 8 adults in 
the United States accounting for over 30 million annual diagnoses (Rosenfeld et al., 2015). 
According to the authors, 20% of all antibiotics prescribed are for the treatment of sinusitis, 
which makes sinusitis the fifth most common diagnosis requiring antibiotic therapy. Research 
shows that despite the availability of national treatment guidelines for acute bacterial 
rhinosinusitis (ABRS) and acute viral rhinosinusitis (AVRS), antibiotics are still being 
overprescribed and continued variability in treatment practices still exist(Rosenfeld et al., 2015). 
According to Rosenfeld (2015), national ambulatory data statistics between 2006-2010 
revealed that rhinosinusitis accounted for more outpatient antibiotic prescriptions than any other 
diagnosis. The CDC specifies that a patient who presents with symptoms less than 7 days in 
duration is unlikely to have a bacterial infection.  Supportive treatments, such as decongestants, 
antihistamines, and nasal washings could provide sufficient therapy for patients with these 
symptoms (Chow et al., 2012). Publications on rhinosinusitis first appeared in the 1970’s. Many 
articles discuss the origin of sinusitis and appropriate treatments. An article written by Hamory, 
Sande, Sydnor, Seale, and Gwaltney (1979) discussed the origin and antimicrobial therapy for 
acute maxillary sinusitis. They studied 81 patients with symptoms of acute sinusitis, who 
underwent direct needle puncture and aspiration of the maxillary sinuses. Streptococcus 
pneumoniae and Haemophilus influenza accounted for 64% of the bacterial strains identified.  
 
 The World Health Organization (WHO) affirmed that the use of clinical practice 
guidelines is at the core of the managerial strategy in every health care system to improve 
diagnosis and therapy (WHO, 2001). The authors believe that in order for guidelines to be 
effective in a clinical practice they must be actively disseminated. Some strategies discussed to 
facilitate dissemination and adoption included local involvement of end-users in the development 
process, presentation of key elements in a simple algorithm or protocol, and dissemination in a 
multi-component program. The WHO’s program would include innovative education and 
monitoring protocols that could impact adherence and reinforcement.  
Alweis, Greco, Wasser, and Wenderoth (2014) examined enhancing the knowledge of 
providers and residents at a specific teaching facility. They implemented three small scale, 
bundled interventions: (1) guidelines sent to each provider by email; (2) CDC Get Smart posters 
placed in examination rooms; and (3) provider education on the CDC Get Smart: Know When 
Antibiotics Work prescription pads. The CDC’s Get Smart Program: Know How Antibiotics 
Work was implemented into the practice not only to provide the patients with some foundational 
information in the waiting rooms and in the exam rooms, but also to offer clinicians knowledge 
and resources.  
In previous bodies of work, researchers have not evaluated clinicians’ treatment of AVRS 
and ABRS by examining the impact of a national education toolkit and a decision tree tool. It is 
the intent of this scholarly project to determine whether an educational program based on a 
national education toolkit plus a decision tree tool offered to health care providers in a Middle 
Tennessee walk-in clinic, promoted an increase in treatment guideline adherence when 
diagnosing and treating acute bacterial rhinosinusitis and acute viral rhinosinusitis.  
 
 
Theoretical Framework 
The Promoting Action on Research Implementation in Health Services framework 
(PARiHS) is a strategy for successfully implementing evidence into practice. It was initially 
published by Kitson and colleagues as an unnamed framework in 1998 focusing on practice 
improvement and guideline implementation efforts. The framework was refined and published in 
2002. After additional evidence review, the developers created and published three central 
elements in 2004. Finally, in 2008, a two-step process was developed for PARiHS (Helfrich et 
al., 2010).  
PARiHS is comprised of three main elements: evidence (E), which are sources of 
knowledge as perceived by multiple stakeholders; context (C), which is the quality of the 
environment where the research will be conducted; and facilitation (F), which are the techniques 
people utilize to support to change, i.e. attitudes, behaviors, skills, and/or thinking (Helfrich et 
al., 2010).  
There are three or four sub-elements for each of the main elements that further explain 
and support each of the elements. Within the element ‘evidence’, the four sub-elements include 
research evidence from studies and clinical practice guidelines, formal experiments; clinical 
experience/professional knowledge; patient preferences and experiences; and project 
evaluation/quality improvement initiatives. For the element ‘context’, the sub-elements include 
receptive context/environment; organizational culture, leadership, and evaluation. Lastly, for the 
element ‘facilitation’, the sub-elements comprise purpose, role of the facilitator, and the 
skills/attributes of the facilitator (Helfrich et al., 2010).  
Since its creation, the PARiHS framework has been utilized many times or cited in 
literature by many researchers. According to Ullrich, Sahay, and Stetler (2014), it has rich 
 
empirical support and strength for implementation projects that cannot be denied. However, 
because many of these researchers have not operationalized all of the key components of the 
framework, research is limited on how well this framework works in its entirety. One article 
demonstrated PARiHS’ use in a quasi-experimental research design study. Sving, Hogman, 
Mamhidir, and Gunningberg (2014) examined knowledge and attitudes of nurses regarding 
pressure ulcer prevention in a hospital setting.  The intervention was based on the PARiHS 
framework and included a multi-disciplinary team, training, and repeat quality measures. 
The PARiHS framework was prospectively applied to this scholarly project because of its 
three main elements. The evidence included the clinical practice guidelines, CDC Get Smart 
program, and the adjusted decision tree tool that the project leader used as the foundation for 
provider education. The context of the project included support from organizational leadership, 
receptive environment to learning, and a known clinical environment to the project leader. The 
facilitation aspect contained the implementation of the project, Get Smart program materials, and 
the decision tree tool. Sving, Hogman, Mamhidir, & Gunningberg (2014) stated that successful 
implementation occurs when evidence was expansive, context/environment was receptive to 
change, and the process of change was facilitated appropriately.  
Methods 
Participants 
 The participants included eight health care providers (7 family nurse practitioners and 1 
physician assistant) employed by a walk-in clinic in Middle Tennessee. The convenience sample 
included providers who rotated between three locations. Exclusion was determined if they were 
not an employee of the specified clinic.  
 
 
Materials 
Pre- and post- questionnaires were completed during the educational luncheon (See 
appendices A & B). The questionnaires were adapted from Alweis et al. (2014). The 
questionnaires remained anonymous and were reviewed for responses. The educational luncheon 
session was based on the Infectious Diseases Society of America (IDSA) treatment guideline on 
rhinosinusitis (Chow et al., 2012), information on the decision tree model the project leader 
created, discussion on most frequent codes used for diagnoses in the clinic, and the CDC’s Get 
Smart program documents. The program documents consisted of handouts, pamphlets, patient 
teaching sheets, posters, viral prescription pads, and antibiotic teaching sheets. The information 
was presented in a PowerPoint format and allowed time for questions.   
 The CDC Get Smart program is a free educational program for providers and patients. 
The CDC’s Get Smart program provides documents for laypersons and providers on how 
antibiotics work for particular well-known illnesses and helps to decrease overprescribing of 
antibiotics. The educational tools within the program allow for increased knowledge of common 
diseases seen in primary care linked to antibiotic over-prescription. The tools provide 
knowledge, not only on the diseases, but also recommended treatment regimens including non-
antibiotic options.  
These tools provide an excellent way to educate the public on the differences between 
viral and bacterial infections, but also when it is necessary to prescribe an antibiotic. Additional 
information about the Get Smart Program is available at:  
http://www.cdc.gov/getsmart/community/about/should-know.html. The decision tree tool was a 
modification of Chow et al. (2012) algorithm using patient symptoms and symptom timing to 
 
diagnosis and manages ABRS. The project leader adapted the published algorithm to incorporate 
a viral component to assist providers in diagnosing AVRS. (See Appendices C, D, E, F, G & I).  
Design 
The project was a quasi-experimental one-group, pre-post without randomization design. 
This design was chosen to answer questions regarding the pre- and post-treatment observed 
behavior of the participants.  Three bundled small-scale interventions were implemented to 
determine the impact on treatment guideline adherence for acute bacterial and viral 
rhinosinusitis.  The independent variables were the CDC’s Get Smart Program, the educational 
luncheon curriculum, and the decision tree tool. The dependent variables in this project were 
provider knowledge and providers’ treatment of AVRS and ABRS. Change in knowledge was 
measured through the pre- and post-education questionnaires. Providers’ treatment of AVRS and 
ABRS was measured through chart reviews. Description of these items will be further discussed 
in the Procedure section.  
Procedure 
 The 45-minute educational curriculum was provided at a luncheon to the providers in 
September 2015. Four clinicians were able to attend the initial session, plus administrative and 
nursing staff. The four participants completed consent and pre-test questionnaires. The 
questionnaire asked the providers questions regarding their personal experience and perceptions 
on treatment guidelines. The program curriculum included a discussion and review of the IDSA 
guideline on rhinosinusitis, education on utilizing the decision tree tool, and education on the 
CDC’s Get Smart: Know When Antibiotics Work program.  
The providers were shown all of the components of the Get Smart program (posters, 
handouts, brochures, fliers, teaching sheets, and viral prescription pad given to patients if 
 
diagnosed with AVRS). Following the completion of the educational curriculum, the providers 
completed a post-questionnaire to evaluate change in his/her knowledge and if they found the 
treatment guidelines and decision tree tool beneficial.  The four participants who were not able to 
attend the group educational session received education on four different occasions because of 
schedule conflicts.  
Using the electronic medical record (EMR) system (Touchworks), an IT associate 
compiled the charts by dates of visit, diagnoses, medical record numbers, providers participating 
in the educational sessions, and clinic location in a spreadsheet. This information allowed the 
project leader to analyze treatment patterns of the providers who had the opportunity to 
participate in the educational sessions.  
Data collection occurred from October through December, 2015. Charts were viewed by 
medical record number (MRN). Once identified by the MRN, the project leader viewed the HPI 
for symptoms, diagnoses, and plan for treatment regimen. Symptoms identified included nasal 
congestion, sore throat, fever, cough, and/or nasal drainage. Timing of symptoms identified was 
grouped as: 1-2 days, 3-4 days, 5-10 days, and > 10 days. Diagnoses included ABRS or AVRS. 
ABRS was coded as sinusitis. AVRS was coded as viral syndrome or URI. Pediatric cases (age < 
17) and diagnoses other than sinusitis, upper respiratory infection, and viral syndrome were 
excluded. 
Antibiotic treatments included were Augmentin 875 mg, Augmentin 2000 mg, 
Doxycycline 100 mg, and/or Levofloxacin 500 mg. Supportive therapies that were identified 
included antihistamines, decongestants, nasal washings, and/or corticosteroid nasal sprays. 
Teaching modalities that were identified and included were CDC viral prescription pad, 
antibiotic teaching sheet, and/or follow-up recommendations. Each symptom, timing of 
 
symptom, diagnosis, prescriptive modality, supportive therapy, and teaching modality was coded 
as a dichotomous variable (yes/no), when identified in the chart.  
Results 
There were 8 providers who participated in the study; 7 were nurse practitioners and 1 
was a physician assistant. At the educational luncheon 4 participants received the education; 
which included four providers (3 NP, 1 PA). Four other providers received their education at 
other times due to competing priorities (Table 1). A total of 114 charts were reviewed, with a 
retrospective chart review on 65 (57%) charts before the educational session and 49 (43%) charts 
reviewed after the educational session.  The 114 charts reviewed included 56 ABRS diagnoses 
and 58 AVRS diagnoses (Table 2).  
The project leader compared whether the training had any influence on the providers’ 
ability to correctly diagnose ABRS and AVRS. The percentage of records with a likely diagnosis 
of ABRS or AVRS prior to implementation of the educational session was 49% (n = 32) for 
ABRS and 51% (n = 33) for AVRS. A Chi-square test was performed and this measure showed 
no statistical difference during the post-training phase of the study [n = 24(49%), 25(51%); (p = 
1.000)] (Figure 1). 
Nasal drainage and fever are primary symptoms that patients present when diagnosed 
with ABRS or AVRS. It is important to note that these symptoms present in ABRS during the 3-
4 days of duration. If not diagnosed with ABRS, then it is presumed the illness is AVRS. Based 
on agreement with the Chow et al. (2012) guidelines, among patients who present to the clinic 
with symptoms within 1-2 days of duration, the providers diagnosed 2 cases of ABRS (6%). At 
1-2 days of symptom duration, 94% of the cases were diagnosed as AVRS (n = 31). A Chi-
 
square test was performed and there was a statistical significance and a relationship found 
between timing of symptoms and diagnoses (p = 0.000).  
Providers diagnosed 22 cases of ABRS (59.5%) versus 15 cases of AVRS (40.5%) 
appropriately based on the guidelines, within 3-4 days of duration. A Chi-square test was 
performed, which resulted in a statistically significant relationship found between timing of 
symptoms and diagnoses (p = 0.000).   In addition, providers diagnosed 17 cases of ABRS (61%) 
when compared to 11 cases of AVRS (39%), when patients presented with symptoms within 5-
10 days duration.  As previously noted, a Chi-square test was performed and there was a 
statistical significant relationship between timing of symptoms and diagnoses (p = 0.000).  At the 
3-4 and 5-10 day symptom range, when comparing the diagnoses of AVRS and ABRS; there was 
a fairly even split between the two diagnostic categories.   
Lastly, patients who presented with symptoms to the clinic at > 10 days of duration were 
appropriately diagnosed with ABRS 94% of the time (15 of 16 cases). A Chi-square test was 
performed on the data. Among providers, there was a statistical significance in the relationship 
between timing of symptoms > 10 days of duration and significance (p = 0.000)  (Figure 2). Of 
note, it was determined that providers did not ask and/or document the discriminating questions 
that would allow for the distinction of whether the provider was applying the guideline, when 
patients presented with symptom duration of 5-10 days and >10 days. Additionally, the project 
compared whether there was a change in how supportive therapies were recommended for 
AVRS after the educational session. The percentage of providers who documented supportive 
treatments prior to the implementation of the intervention was 29%. Participants’ 
recommendation of supportive therapies after the educational session was unchanged based on a 
Chi-square test (n =19; p = .320) (Figure 3). 
 
Discussion 
In this study, the providers appropriately diagnosed and treated patients with symptoms 
lasting 1-2 days and > 10 days consistently. No antibiotics were prescribed when patients were 
diagnosed with AVRS at 1-2 days of symptoms.  However, if the patient was diagnosed with 
ABRS, antibiotic therapy was consistent with the guidelines  When patients reported symptoms 
of 3-4 and 5-10 days in duration, charts showed variability in clinician diagnosis and treatment of 
AVRS and ABRS.  Possible causes of the variability could be clinicians’ experience with the 
guidelines, patients’ symptoms and patients’ presentation at time of visit.   
Documentation of supportive therapies was inconsistent without differentiation for 
diagnosis or symptom duration. Of note, providers’ knowledge of guideline adherence was not 
tested for change after implementation of program components, such as the decision tree tool and 
the CDC Get Smart Program. Due to a small convenience sample, the questionnaires’ 
quantitative results from the clinicians were not utilized and a change in knowledge was 
undetermined before or after the educational session.  
Qualitative data gathered through questionnaires suggested a positive response to both 
the decision tree tool and the CDC Get Smart program items distributed. Although the providers 
found the tool and program beneficial, there was no documented use of these items in the 
electronic medical record.  A possible resolution would be to embed the tools in the electronic 
chart for ease of use, visualization, application, and documentation.  
For symptoms ranging from 5-10 and > 10 days, a provider would need to ask a 
discriminating question, (such as “Did your symptoms improve and then get worse?” or “Are 
your symptoms improving?”) and document this information, along with the patient’s current 
symptoms in order for to comply with the guidelines. However, the discriminating question and 
 
documentation were missing from the reviewed charts both before and after the educational 
session. Because the information was absent from the chart, one would have to consider if the 
providers used the discriminating questions in their diagnostic reasoning. The conclusion might 
demonstrate a lack of guideline/decision tree utilization. 
 Additional research is needed to determine the cause of variability in treatment for those 
patients with symptoms lasting 3-4 and 5-10 days.  Likewise, further education is warranted for 
providers to become more knowledgeable in the use of the guideline, which could result in the 
providers probing for additional information and documenting appropriately. Although the 
project leader believes that education is a valuable and necessary component for supporting 
positive practice change, the educational session and CDC materials were not sufficient to create 
change in this project.  For those interested in promoting guidelines adherence, consideration of 
strategies in addition to an education session and the CDC materials may lead to improved 
likelihood of provider behavior change. 
Conclusion 
Guideline adherence of providers can vary, depending on knowledge of the present 
illness and practice styles. Most providers are guided by their clinical expertise and some other 
area of influence. The education session, the modified decision tool and the CDC Program 
materials showed no difference on the clinicians’ practice behavior. Similarly, the study revealed 
variations in how clinicians are treating patients who seek treatment with 3-10 days of URI 
symptoms. Additional strategies, such as discussion or further research, are needed to assist 
providers in their ability to discriminate between these symptoms for improved diagnoses of 
ABRS and AVRS. 
 
  In this project, it was shown that education of the provider on guidelines did not show 
any statistical difference in their practice behavior. More research and discussion are needed in 
this specific subject to enhance the providers’ knowledge on the appropriate tools and resources 
used to discriminate between viral and bacterial illness. Additional research is needed to identify 
other modes of education delivery that can lead to improved diagnoses of ABRS and AVRS. 
Ultimately, this improvement will lead to additional understanding that will aid in decreasing the 
improper use of antibiotics.  
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Appendix A 
Pre-Questionnaire for Providers on Guideline Adherence 
 
1.) How many years has it been since you completed your original certification or most 
recent recertification?  
a. 0-5 years 
b. 6-10 years 
c. 11-15 years 
d. More than 15 years 
2.) When was the last time you went to an educational conference of any type?  
a. 0-1 years 
b. 2-4 years 
c. 5-7 years 
d. 8 or more years 
3.) When was the last time that you went to an educational conference that covered a topic 
dealing with allergies and/or sinusitis? 
a. 0-1 years 
b. 2-4 years 
c. 5-7 years 
d. 8 or more years 
4.) For the diagnosis of acute bacterial rhinosinusitis, how well do you believe that you know 
the treatment guidelines?  
a. Not at all 
b. Mildly well 
 
c. Moderately well 
d. Very well 
5.) For the diagnosis of acute bacterial rhinosinusitis, how often do you believe you prescribe 
antibiotics in a guideline adherent manner?  
a. 0-25% of the time 
b. 26-50% of the time 
c. 51-75% of the time 
d. 76-100% of the time 
6.) For each of the following factors that might influence your decision to prescribe 
antibiotics, please indicate the importance of each factor:  
a. Patient desires antibiotics 
i. Not at all important  
ii. Mildly important 
iii. Moderately important  
iv. Very important 
b. Uncertainty in diagnosis 
v. Not at all important 
vi. Mildly important 
vii. Moderately important 
viii. Very important 
c. Clinician lack of knowledge in treatment guidelines  
ix. Not at all important 
x. Mildly important 
 
xi. Moderately important 
xii. Very important 
d. Lack of clinical decision support tools 
xiii. Not at all important  
xiv. Mildly important 
xv. Moderately important 
xvi. Very important 
  
 
Appendix B 
Post-Questionnaire for Providers on Guideline Adherence 
 
7.) How many years has it been since you completed your original certification or most 
recent recertification?  
a. 0-5 years 
b. 6-10 years 
c. 11-15 years 
d. More than 15 years 
8.) For the diagnosis of acute bacterial rhinosinusitis, how well do you believe that you know 
the treatment guidelines?  
a. Not at all 
b. Mildly well 
c. Moderately well 
d. Very well 
9.) For the diagnosis of acute bacterial rhinosinusitis, how often do you believe you prescribe 
antibiotics in a guideline adherent manner?  
a. 0-25% of the time 
b. 26-50% of the time 
c. 51-75% of the time 
d. 76-100% of the time 
 
 
 
10.) For each of the following factors that might influence your decision to prescribe 
antibiotics, please indicate the importance of each factor:  
a. Patient desires antibiotics 
i. Not at all important  
ii. Mildly important 
iii. Moderately important  
iv. Very important 
b. Uncertainty in diagnosis 
i. Not at all important 
ii. Mildly important 
iii. Moderately important 
iv. Very important 
c. Clinician lack of knowledge in treatment guidelines  
i. Not at all important 
ii. Mildly important 
iii. Moderately important 
iv. Very important 
d. Lack of clinical decision support tools 
i. Not at all important  
ii. Mildly important 
iii. Moderately important 
iv. Very important 
 
11.) During this educational luncheon, did you learn any new information learned 
about national treatment guidelines for acute bacterial rhinosinusitis? 
a. Yes 
b. No 
c. Somewhat 
12.) Due to this information, will your prescribing habits change? 
a. Definitely 
b. Maybe  
c. No 
d. I don’t know 
13.) Will you use the Decision Tree tool in your clinical practice? 
a. Definitely 
b. Maybe 
c. No 
d. I don’t know 
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Appendix H 
 
Table 1. 
 
Demographics: Providers 
 
Nurse Practitioners Physician Assistants 
7 1 
 
 
Table 2.  
 
Demographics: Total Charts Before/After Training 
 
Before Educational Session After Educational Session 
65 (57%) 49 (43%) 
 
 
Table 3. 
 
Likely Diagnosis cases Before/After Training 
 
 Before Training  After Training 
ABRS (n = 56) 57.1% (n=32) 42.9% (n=24) 
AVRS (n = 58) 56.9% (n=33) 43.1% (n=25) 
(n = 114; p = 1.000) 
 
  
 
 
Figure 1. 
Likely Diagnoses Before and After Educational Session 
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Table 4. 
 
# of cases: Timing of Symptoms and Diagnoses of AVRS and ABRS 
 
 1-2 days  3-4 days 5-10 days ➢ 10 days  
ABRS 2 22 17 15 
AVRS 31 15 11 1 
 
 
Figure 2.  
 
Timing of symptoms and diagnosis of ABRS and AVRS 
 
 
(n = 114; p = 0.000)    
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Figure 3.  
 
Supportive treatment recommendations before and after educational session 
 
 
 
(n = 19, 19; p = .320) 
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